Risk & Development Strategy to Bring Novel & First-in-Class ADCs to the Clinic
11:45 am - Tuesday 9th March 2027
- Emphasising the importance of pursuing novel targets amongst a crowded clinical landscape
- Contextualising learnings from progressing a novel target ADC to clinical trials to develop ADCs with meaningful patient impact
- Incorporating learnings from historical profiles of adjacent target ADC: What are the indications of promising performance?
